Olah M E, Stiles G L
Duke University Medical Center, Department of Medicine, Durham, North Carolina 27710, USA.
Annu Rev Pharmacol Toxicol. 1995;35:581-606. doi: 10.1146/annurev.pa.35.040195.003053.
Adenosine receptors (ARs) are members of the G protein-coupled receptor family and mediate the multiple physiological effects of adenosine. Currently, four AR subtypes have been cloned: A1AR, A2aAR, A2bAR, and A3AR. All subtypes are distinctly distributed throughout the body and AR agonists and antagonists have potential therapeutic utility. Knowledge of AR amino acid structure has been utilized in mutagenesis studies to identify specific receptor regions that interact with distinct classes of ligands. Cloning of ARs has also permitted receptor regulatory processes such as desensitization to be studied in greater detail, in particular, the molecular mechanisms underlying this event. Cloning of the human A1AR has revealed that alternate splicing generates distinct receptor transcripts. The existence of a particular transcript in a tissue or cell apparently regulates the level of A1AR expression in the tissue. This review focuses on these aspects of AR structure and function and their therapeutic regulation.
腺苷受体(ARs)是G蛋白偶联受体家族的成员,介导腺苷的多种生理效应。目前,已克隆出四种AR亚型:A1AR、A2aAR、A2bAR和A3AR。所有亚型在全身均有明显分布,AR激动剂和拮抗剂具有潜在的治疗用途。AR氨基酸结构的知识已用于诱变研究,以确定与不同类配体相互作用的特定受体区域。AR的克隆还使得受体调节过程(如脱敏)能够得到更详细的研究,特别是这一过程背后的分子机制。人A1AR的克隆表明,可变剪接产生不同的受体转录本。组织或细胞中特定转录本的存在显然调节了该组织中A1AR的表达水平。本综述重点关注AR结构和功能的这些方面及其治疗调节。